Zhide Vision Completes Series A Funding Round to Advance Precision Ophthalmic Diagnostics Market

VCBeat has learned that Zhide Yuanjian Technology (Beijing) Co., Ltd., a company dedicated to developing a full product matrix for precision medicine in ophthalmology, has completed an A-round financing of nearly RMB 100 million. This round was co-led by the Beijing Pharmaceutical and Health Industry Investment Fund and Shunxi Venture Capital Fund Management under Beijing State-owned Capital Operation and Management Group, with joint investment from the Shunyi District Shunchuang Industrial Investment Management Fund.

Zhide Yuanjian is a medical group integrating medical testing, novel drug R&D, and innovative medical device development. Specializing in ocular fluid analysis, it focuses on precision diagnosis and treatment in ophthalmology. Its services cover more than 1,100 hospitals across 24 provinces in China. “For ophthalmic testing, choose Zhide” has become the top-of-mind choice for ophthalmologists.

Zhide has achieved rapid growth, securing angel and Series A financing over the past four years from prominent healthcare investment institutions, including Northern Light Venture Capital, Yuanyi Capital, Beijing Pharmaceutical and Health Industry Investment Fund, Shunxi Venture Capital Fund Management, and Shunchuang Industrial Investment Management Fund. Its headquarters and laboratories are located in Shunyi District, Beijing, while its R&D and production bases are situated in Xinwu District, Wuxi.

The primary use of the company’s latest financing round is to develop an integrated intelligent workstation for analyzing ocular fluid components, as well as self-test cards for common eye diseases designed for home-based self-screening scenarios. Leveraging the prominent intellectual property advantage of founder Professor Tao Yong in the field of ophthalmology, the company aims to build service channels that integrate online support with offline services, including consultations for common eye diseases, home-based self-examinations, and home delivery of medications. Committed to serving eye disease patients comprehensively, Zhide Yuanjian’s long-term vision and goal is to “make it easy to maintain healthy eyes.”

The Beijing Pharmaceutical and Health Industry Investment Fund is a government investment fund established by Beijing in late 2023, focusing on key industrial sectors such as innovative drugs and innovative medical devices, as well as emerging fields including cell and gene therapy and digital health.

Beijing Shunxi Venture Capital Fund Management Co., Ltd. (hereinafter referred to as “Shunxi Management”) is a subsidiary of Beijing State-owned Capital Operation and Management Co., Ltd. (hereinafter referred to as “Beijing Guoguan”) and serves as its venture capital investment platform. Adhering to its functional positioning as a venture capital platform, Shunxi Management focuses on early-stage and small-scale investments, targeting high-quality early-stage projects in the fields of technological innovation and healthcare. By establishing market-oriented operational and management mechanisms, the company is committed to becoming a first-class venture capital investment platform in China.

Beijing Shunchuang Industrial Entrepreneurship Investment Management Co., Ltd. was established in January 2023 as a fund management company funded by Beijing Shunyi Technology Innovation Group Co., Ltd. As the first market-oriented private equity direct investment fund manager in Shunyi District, Shunchuang Industrial Investment focuses on the development of advantageous industries in Shunyi District, with key investments in high-tech and advanced sectors such as third-generation semiconductors, aerospace, new energy intelligent vehicles, next-generation information technology, pharmaceuticals and healthcare, intelligent equipment, and smart manufacturing. By leveraging capital support and adopting an investment-driven attraction strategy, the company facilitates effective coordination among capital, assets, and resources in Shunyi District, promoting the implementation, upgrading, and innovative development of related industries. To date, it has established five market-oriented funds and, in collaboration with the Houshayu Town Government, launched Shunyi District’s first town-level fund.